Upon approval of simvastatin (generic Zocor®), Express Scripts worked to secure its substitution for Lipitor®, another anti-cholesterol drug. This move “against” Lipitor was unprecedented. Typically, pharmacy benefit managers only sought to hasten replacement of a brand drug by its generic equivalent.
The communications program supporting greater use of simvastatin and other generics won a Public Relations Society of America Silver Anvil Award of Excellence. Click here for the PRSA award submission, “Helping Americans Save Billions with Generic Drugs,” and a New York Times article, “Lipitor or Generic? Billion-Dollar Battle Looms.”
In the face of a worldwide shortage of critical medical isotopes, Mallinckrodt/Covidien added a new reactor source to the global supply chain. Located outside of Warsaw, Poland, the Maria reactor now supplies Mo-99 to the company’s processing facility in Petten, the Netherlands for the production of Tc-99 generators.
Steve played an important role in securing government permits and licenses needed in Poland and for transport across Europe. He also produced and led a Warsaw news conference announcing the company’s new relationship with the Maria reactor. Click here for an American Chamber of Commerce in Poland article, “The Art of Irradiation,” and a New York Times article, “New Source of an Isotope in Medicine is Found.”
Steve visually captured the year ahead for healthcare’s dramatic transformation with a series of one-page infographics for pharma, medical devices, health insurance and healthcare delivery. As the news release announcing the outlooks explained, “Healthcare’s story in 2015 will be about dramatically changing roles and relationships as pressures on cost, quality and outcomes drive providers, insurers, manufacturers and consumers to engage in new and different ways.” Click here for the Numerof 2015 Outlooks.